Universal-Beteiligungs- und Servicegesellschaft
TRVI icon

Universal-Beteiligungs- und Servicegesellschaft’s Trevi Therapeutics TRVI Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644K Sell
34,554
-1,910
-5% -$27.8K ﹤0.01% 1717
2026
Q1 		$435K Buy
+36,464
New +$408K ﹤0.01% 1765

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's TRVI Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Trevi Therapeutics (TRVI) stake by 5.2% in Q2 2026, selling an estimated $27.8K and leaving 34,554 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in TRVI in Q1 2026 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 34,554 shares of Trevi Therapeutics worth $644K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 1,910 Trevi Therapeutics shares in Q2 2026, an estimated $27.8K.
  • Trevi Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1717 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Trevi Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.